Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vikas Gupta

Showing results (591-600 of 792) with videos related to

Pageof 80
Sort By:
The Lancet. Haematology|December 25, 2017
Momelotinib versus best available therapy in patients with myelofibrosis previously treated with ruxolitinib (SIMPLIFY 2): a randomised, open-label, phase 3 trialClaire N Harrison, Alessandro M Vannucchi, Uwe Platzbecker, et al.
Cancer|February 21, 2008
Outcome of patients who develop acute leukemia or myelodysplasia as a second malignancy after solid tumors treated surgically or with strategies that include chemotherapy and/or radiationArwa Abdelhameed, Gregory R Pond, Nicholas Mitsakakis, et al.
Therapeutic Advances in Infectious Disease|August 9, 2019
Antimicrobial susceptibility patterns of organisms causing secondary abdominal infections in patients with perforated abdominal viscusPraveen Kumar-M, Nusrat Shafiq, Pradeep Kumar, et al.
Annals of Internal Medicine|August 26, 2024
Endoscopic Ultrasound-Guided Rendezvous Technique Versus Precut Sphincterotomy as Salvage Technique in Patients With Benign Biliary Disease and Difficult Biliary Cannulation : A Randomized Controlled TrialArup Choudhury, Jayanta Samanta, Gaurav Muktesh, et al.
Journal of Clinical and Experimental Hepatology|November 17, 2023
Sonographic "Cervix Sign": A New Ancillary Sign of Gallbladder Neck MalignancyPratyaksha Rana, Himanshu Pruthi, Pankaj Gupta, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 6, 2012
HLA-matched sibling transplantation for severe aplastic anemia: impact of HLA DR15 antigen status on engraftment, graft-versus-host disease, and overall survivalMinoo Battiwalla, Tao Wang, Jeanette Carreras, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 1, 2004
Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemiaVikas Gupta, Sarah E Ball, Qi-long Yi, et al.
Neurology India|October 9, 2015
Giant cell arteritis in India: Report from a tertiary care center along with total published experience from IndiaAman Sharma, Vinay Sagar, Mahesh Prakash, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 4, 2017
Long-Term Incidence of Secondary Malignancies after Allogeneic Hematopoietic Cell Transplantation: A Single-Center ExperienceFotios V Michelis, Rouslan Kotchetkov, Rebecca M Grunwald, et al.
British Journal of Haematology|December 10, 2009
Alemtuzumab is safe and effective as immunosuppressive treatment for aplastic anaemia and single-lineage marrow failure: a pilot study and a survey from the EBMT WPSAAAntonio Maria Risitano, Carmine Selleri, Bianca Serio, et al.
Pageof 80

Showing results (591-600 of 792) with videos related to

Sort By:
Pageof 80
The Lancet. Haematology|December 25, 2017
Momelotinib versus best available therapy in patients with myelofibrosis previously treated with ruxolitinib (SIMPLIFY 2): a randomised, open-label, phase 3 trialClaire N Harrison, Alessandro M Vannucchi, Uwe Platzbecker, et al.
Cancer|February 21, 2008
Outcome of patients who develop acute leukemia or myelodysplasia as a second malignancy after solid tumors treated surgically or with strategies that include chemotherapy and/or radiationArwa Abdelhameed, Gregory R Pond, Nicholas Mitsakakis, et al.
Therapeutic Advances in Infectious Disease|August 9, 2019
Antimicrobial susceptibility patterns of organisms causing secondary abdominal infections in patients with perforated abdominal viscusPraveen Kumar-M, Nusrat Shafiq, Pradeep Kumar, et al.
Annals of Internal Medicine|August 26, 2024
Endoscopic Ultrasound-Guided Rendezvous Technique Versus Precut Sphincterotomy as Salvage Technique in Patients With Benign Biliary Disease and Difficult Biliary Cannulation : A Randomized Controlled TrialArup Choudhury, Jayanta Samanta, Gaurav Muktesh, et al.
Journal of Clinical and Experimental Hepatology|November 17, 2023
Sonographic "Cervix Sign": A New Ancillary Sign of Gallbladder Neck MalignancyPratyaksha Rana, Himanshu Pruthi, Pankaj Gupta, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 6, 2012
HLA-matched sibling transplantation for severe aplastic anemia: impact of HLA DR15 antigen status on engraftment, graft-versus-host disease, and overall survivalMinoo Battiwalla, Tao Wang, Jeanette Carreras, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 1, 2004
Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemiaVikas Gupta, Sarah E Ball, Qi-long Yi, et al.
Neurology India|October 9, 2015
Giant cell arteritis in India: Report from a tertiary care center along with total published experience from IndiaAman Sharma, Vinay Sagar, Mahesh Prakash, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 4, 2017
Long-Term Incidence of Secondary Malignancies after Allogeneic Hematopoietic Cell Transplantation: A Single-Center ExperienceFotios V Michelis, Rouslan Kotchetkov, Rebecca M Grunwald, et al.
British Journal of Haematology|December 10, 2009
Alemtuzumab is safe and effective as immunosuppressive treatment for aplastic anaemia and single-lineage marrow failure: a pilot study and a survey from the EBMT WPSAAAntonio Maria Risitano, Carmine Selleri, Bianca Serio, et al.
Pageof 80